4.5 Review

Tobacco nitrosamines as culprits in disease: mechanisms reviewed

Journal

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
Volume 72, Issue 1, Pages 107-120

Publisher

SPRINGER
DOI: 10.1007/s13105-016-0465-9

Keywords

Tobacco-specific nitrosamine; NNK; Smoking; Nicotine; Carcinogenesis; Adduct; Neurodegeneration; Diabetes; Tobacco

Funding

  1. National Institutes of Health [F32AA024018, AA-11431, AA-12908]

Ask authors/readers for more resources

The link between tobacco abuse and cancer is well-established. However, emerging data indicate that toxins in tobacco smoke cause cellular injury due to enhanced toxic/metabolic effects of metabolites, disruption of intracellular signaling mechanisms, and formation of DNA, protein, and lipid adducts that impair function and promote oxidative stress and inflammation. These effects of smoking, which are largely non-carcinogenic, can be produced by tobacco-specific nitrosamines and their metabolites. These factors could account for the increased rates of neurodegeneration and insulin resistance diseases among smokers. Herein, we review nicotine and tobacco-specific nitrosamine metabolism, mechanisms of adduct formation, DNA damage, mutagenesis, and potential mechanisms of disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease

Suzanne M. de la Monte, Ming Tong, Irio Schiano, John Didsbury

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Public, Environmental & Occupational Health

Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons

Chukwuemeka N. Okafor, Natalie E. Kelso, Vaughn Bryant, Larry E. Burrell, Maria Jose Miguez, Assawin Gongvatana, Karen T. Tashima, Suzanne de la Monte, Robert L. Cook, Ronald A. Cohen

PSYCHOLOGY HEALTH & MEDICINE (2017)

Article Pathology

Primary Spinal Epidural CIC-DUX4 Undifferentiated Sarcoma in a Child

John E. Donahue, Evgeny Yakirevich, Shan Zhong, Diana O. Treaba, Nelli S. Lakis, Siraj M. Ali, Suzanne M. de la Monte, Shamlal Mangray

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2018)

Article Substance Abuse

Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics

Suzanne M. de la Monte, Jared Kay, Emine B. Yalcin, Jillian J. Kril, Donna Sheedy, Greg T. Sutherland

ALCOHOL (2018)

Meeting Abstract Pharmacology & Pharmacy

DECREASED CYP3A4 ACTIVITY AND PROTEIN IN NONALCOHOLIC FATTY LIVER (NAFL) AND NONALCOHOLIC STEATOHEPATITIS (NASH)

Rohitash Jamwal, Benjamin J. Barlock, Sravani Adusumalli, Ken Ogasawara, Suzanne M. De La Monte, Fatemeh Akhlaghi

DRUG METABOLISM AND PHARMACOKINETICS (2018)

Article Pediatrics

Neuroinflammation-Related Encephalopathy in an Infant Born Preterm Following Exposure to Maternal Diabetic Ketoacidois

David E. Mandelbaum, Amanda Arsenault, Barbara S. Stonestreet, Stefan Kostadinov, Suzanne M. De La Monte

JOURNAL OF PEDIATRICS (2018)

Article Geriatrics & Gerontology

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines

Brian R. Ott, Richard N. Jones, Lori A. Daiello, Suzanne M. de la Monte, Edward G. Stopa, Conrad E. Johanson, Charles Denby, Paula Grammas

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

Suzanne M. de la Monte, Ming Tong, Andrew J. Hapel

Summary: Neuroinflammation may serve as a pathogenic mediator and biomarker of neurodegeneration in the transition between mild cognitive impairment (MCI) and early-stage Alzheimer's disease (AD). This study suggests that early management of MCI/AD neuroinflammation should involve both anti-inflammatory and pro-neuroprotective strategies.

BIOMEDICINES (2023)

Article Nutrition & Dietetics

Myriocin Treatment Reverses Alcohol-Induced Alterations in Polyunsaturated Fatty Acid-Containing Phospholipid Expression in the Liver

Emine B. Yalcin, Ming Tong, Camilla Homans, Suzanne M. de la Monte

Summary: Chronic heavy alcohol exposure can cause alcoholic liver disease, but it can be improved by using the serine palmitoyltransferase inhibitor myriocin, which may regulate the composition of hepatic phospholipids containing docosahexaenoic acid and arachidonic acid.

NUTRITION AND METABOLIC INSIGHTS (2022)

Article Pediatrics

Neuropathologic Findings in a Child with a Novel Variant of TBCK-Related Encephaloneuronopathy

Sonja Chen, Fouad Zakkat, Salwa Khedrt, Shamlal Mangrayt, Lauren Massingham, Suzanne M. de la Monte

JOURNAL OF PEDIATRIC NEUROLOGY (2020)

Article Medicine, Research & Experimental

Critical Shifts in Cerebral White Matter Lipid Profiles After Ischemic-Reperfusion Brain Injury in Fetal Sheep as Demonstrated by the Positive Ion Mode MALDI-Mass Spectrometry

Suzanne M. de la Monte, Gina M. Gallucci, Amy Lin, Ming Tong, Xiaodi Chen, Barbara S. Stonestreet

CELL MEDICINE (2020)

Meeting Abstract Substance Abuse

ACCURATE MASS MALDI-TOF/ TOF LIPID IMAGING OF HUMAN BRAIN TISSUE

C. C. Smith, M. B. O'Rourke, M. Padula, S. M. De La Monte, D. L. Sheedy, J. J. Kril, G. T. Sutherland

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2018)

Meeting Abstract Clinical Neurology

Brain Insulin Resistance as a Mediator of Vascular and White Matter Degeneration in AD: Role of ApoE4 Dose

Suzanne de la Monte, Ming Tong, Gina Gallucci, Emine Yalcin, Edward Stopa, Miles Miller, Jared Kay

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

No Data Available